Gomez Lopez Hernandez Syndrome
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Gomez Lopez Hernandez Syndrome

What is the definition of Gomez Lopez Hernandez Syndrome?
Gomez Lopez Hernandez syndrome (GLHS) is a rare condition characterized by partial scalp baldness (alopecia); numbness of the face, eyes, sinuses, and mouth (trigeminal anesthesia); and a brain abnormality called rhombencephalosynapsis. Additional symptoms vary but may include distinctive facial features, intellectual disability or other neurological problems, and craniofacial abnormalities. The cause of GLHS is poorly understood. It may be genetic, possibly with autosomal recessive inheritance.
What are the alternative names for Gomez Lopez Hernandez Syndrome?
  • Gomez Lopez Hernandez syndrome
  • Cerebellotrigeminal dermal dysplasia
  • Cerebellotrigeminal-dermal dysplasia
  • Cerebellotrigeminal-dermal dysplasia syndrome
  • Craniosynostosis-alopecia-brain defect syndrome
  • Gomez-Lopez-Hernández syndrome
Who are the top Gomez Lopez Hernandez Syndrome Local Doctors?
Elite in Gomez Lopez Hernandez Syndrome
Elite in Gomez Lopez Hernandez Syndrome
Sao Paulo, SP, BR 

Eduardo Perrone practices in Sao Paulo, Brazil. Mr. Perrone is rated as an Elite expert by MediFind in the treatment of Gomez Lopez Hernandez Syndrome. His top areas of expertise are Gomez Lopez Hernandez Syndrome, Gingival Fibromatosis with Hypertrichosis, Cherubism, and Aplasia Cutis Congenita.

Bryan V. Pham
Experienced in Gomez Lopez Hernandez Syndrome
Experienced in Gomez Lopez Hernandez Syndrome

Rampart Clinic Neurology & Neuro-Ophthalmology

130 Rampart Way, Suite 150, 
Denver, CO 
Experience:
14+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. Pham is originally from Texas, although having lived in all four of the major time zones of the United States, he is ready to lay down some roots in Colorado. Dr. Pham studied biomedical engineering at the University of Texas at Austin before completing medical school at the University of Texas Medical School at Houston (now known as the McGovern Medical School). He completed an internship and residency in neurology at the Oregon Health & Science University in Portland and completed a fellowship in neuro-ophthalmology at the Weill Cornell Medical College in New York City. After completing his fellowship, Dr. Pham worked in the Denver community as a neurologist and neuro-ophthalmologist before joining SCL Health Medical Group. Dr. Pham is board-certified in neurology by the American Board of Psychiatry and Neurology, and was promoted to fellow member status in the North American Neuro-Ophthalmology Society in 2022. His clinical interests include optic neuritis, idiopathic intracranial hypertension, non-arteritic anterior ischemic optic neuropathy and double vision.“I strive to provide high-quality neurologic and neuro-ophthalmologic care that is tailored to the individual needs of my patients.”When not working, Dr. Pham enjoys playing recreational ice hockey and learning how to cook anything and everything. Dr. Pham is rated as an Experienced provider by MediFind in the treatment of Gomez Lopez Hernandez Syndrome. His top areas of expertise are Increased Intracranial Pressure, Pseudotumor Cerebri Syndrome, Meningitis, and Papilledema.

 
 
 
 
Learn about our expert tiers
Learn More
Anne H. Eberhart
Experienced in Gomez Lopez Hernandez Syndrome
Ophthalmology
Experienced in Gomez Lopez Hernandez Syndrome
Ophthalmology

ETSU Physicians & Associates- Ophthalmology

325 N State Of Franklin Rd, 
Johnson City, TN 
Languages Spoken:
English
Offers Telehealth

. Dr. Eberhart is rated as an Experienced provider by MediFind in the treatment of Gomez Lopez Hernandez Syndrome. Her top areas of expertise are Cataract, Coloboma of Optic Papilla, Coloboma of Optic Nerve, and Choroid Plexus Carcinoma.

What are the latest Gomez Lopez Hernandez Syndrome Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center